Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis
• The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Marchetti, C. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Using regression analysis to predict the future energy consumption of a supermarket in the UK - Braun, M.R. ELSEVIER, 2014, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:83 ; year:2020 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ctrv.2019.101945 |
|---|
| Katalog-ID: |
ELV049103679 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV049103679 | ||
| 003 | DE-627 | ||
| 005 | 20230624151916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200128s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ctrv.2019.101945 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica |
| 035 | |a (DE-627)ELV049103679 | ||
| 035 | |a (ELSEVIER)S0305-7372(19)30166-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 620 |q VZ |
| 082 | 0 | 4 | |a 150 |a 300 |q VZ |
| 084 | |a 77.52 |2 bkl | ||
| 100 | 1 | |a Marchetti, C. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis |
| 264 | 1 | |c 2020 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. | ||
| 650 | 7 | |a Chemotherapy |2 Elsevier | |
| 650 | 7 | |a Treatment |2 Elsevier | |
| 650 | 7 | |a Toxicity |2 Elsevier | |
| 650 | 7 | |a Surgery |2 Elsevier | |
| 650 | 7 | |a Radiotherapy |2 Elsevier | |
| 650 | 7 | |a Survival |2 Elsevier | |
| 650 | 7 | |a Cervical cancer |2 Elsevier | |
| 700 | 1 | |a Fagotti, A. |4 oth | |
| 700 | 1 | |a Tombolini, V. |4 oth | |
| 700 | 1 | |a Scambia, G. |4 oth | |
| 700 | 1 | |a De Felice, F. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Braun, M.R. ELSEVIER |t Using regression analysis to predict the future energy consumption of a supermarket in the UK |d 2014 |g Amsterdam [u.a.] |w (DE-627)ELV01225004X |
| 773 | 1 | 8 | |g volume:83 |g year:2020 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ctrv.2019.101945 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 77.52 |j Differentielle Psychologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 83 |j 2020 |h 0 | ||
| author_variant |
c m cm |
|---|---|
| matchkey_str |
marchetticfagottiatombolinivscambiagdefe:2020----:uvvlntxctinoduathmteaylsugrvrudfntvceoaiteayocriacn |
| hierarchy_sort_str |
2020 |
| bklnumber |
77.52 |
| publishDate |
2020 |
| allfields |
10.1016/j.ctrv.2019.101945 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica (DE-627)ELV049103679 (ELSEVIER)S0305-7372(19)30166-5 DE-627 ger DE-627 rakwb eng 620 VZ 150 300 VZ 77.52 bkl Marchetti, C. verfasserin aut Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Elsevier Fagotti, A. oth Tombolini, V. oth Scambia, G. oth De Felice, F. oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:83 year:2020 pages:0 https://doi.org/10.1016/j.ctrv.2019.101945 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 83 2020 0 |
| spelling |
10.1016/j.ctrv.2019.101945 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica (DE-627)ELV049103679 (ELSEVIER)S0305-7372(19)30166-5 DE-627 ger DE-627 rakwb eng 620 VZ 150 300 VZ 77.52 bkl Marchetti, C. verfasserin aut Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Elsevier Fagotti, A. oth Tombolini, V. oth Scambia, G. oth De Felice, F. oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:83 year:2020 pages:0 https://doi.org/10.1016/j.ctrv.2019.101945 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 83 2020 0 |
| allfields_unstemmed |
10.1016/j.ctrv.2019.101945 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica (DE-627)ELV049103679 (ELSEVIER)S0305-7372(19)30166-5 DE-627 ger DE-627 rakwb eng 620 VZ 150 300 VZ 77.52 bkl Marchetti, C. verfasserin aut Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Elsevier Fagotti, A. oth Tombolini, V. oth Scambia, G. oth De Felice, F. oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:83 year:2020 pages:0 https://doi.org/10.1016/j.ctrv.2019.101945 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 83 2020 0 |
| allfieldsGer |
10.1016/j.ctrv.2019.101945 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica (DE-627)ELV049103679 (ELSEVIER)S0305-7372(19)30166-5 DE-627 ger DE-627 rakwb eng 620 VZ 150 300 VZ 77.52 bkl Marchetti, C. verfasserin aut Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Elsevier Fagotti, A. oth Tombolini, V. oth Scambia, G. oth De Felice, F. oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:83 year:2020 pages:0 https://doi.org/10.1016/j.ctrv.2019.101945 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 83 2020 0 |
| allfieldsSound |
10.1016/j.ctrv.2019.101945 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica (DE-627)ELV049103679 (ELSEVIER)S0305-7372(19)30166-5 DE-627 ger DE-627 rakwb eng 620 VZ 150 300 VZ 77.52 bkl Marchetti, C. verfasserin aut Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Elsevier Fagotti, A. oth Tombolini, V. oth Scambia, G. oth De Felice, F. oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:83 year:2020 pages:0 https://doi.org/10.1016/j.ctrv.2019.101945 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 83 2020 0 |
| language |
English |
| source |
Enthalten in Using regression analysis to predict the future energy consumption of a supermarket in the UK Amsterdam [u.a.] volume:83 year:2020 pages:0 |
| sourceStr |
Enthalten in Using regression analysis to predict the future energy consumption of a supermarket in the UK Amsterdam [u.a.] volume:83 year:2020 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Differentielle Psychologie |
| institution |
findex.gbv.de |
| topic_facet |
Chemotherapy Treatment Toxicity Surgery Radiotherapy Survival Cervical cancer |
| dewey-raw |
620 |
| isfreeaccess_bool |
false |
| container_title |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| authorswithroles_txt_mv |
Marchetti, C. @@aut@@ Fagotti, A. @@oth@@ Tombolini, V. @@oth@@ Scambia, G. @@oth@@ De Felice, F. @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV01225004X |
| dewey-sort |
3620 |
| id |
ELV049103679 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049103679</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624151916.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200128s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ctrv.2019.101945</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049103679</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0305-7372(19)30166-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">300</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Marchetti, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Toxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Surgery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fagotti, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tombolini, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scambia, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Felice, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Braun, M.R. ELSEVIER</subfield><subfield code="t">Using regression analysis to predict the future energy consumption of a supermarket in the UK</subfield><subfield code="d">2014</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01225004X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:83</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ctrv.2019.101945</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.52</subfield><subfield code="j">Differentielle Psychologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">83</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Marchetti, C. |
| spellingShingle |
Marchetti, C. ddc 620 ddc 150 bkl 77.52 Elsevier Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis |
| authorStr |
Marchetti, C. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV01225004X |
| format |
electronic Article |
| dewey-ones |
620 - Engineering & allied operations 150 - Psychology 300 - Social sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
620 VZ 150 300 VZ 77.52 bkl Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer Elsevier |
| topic |
ddc 620 ddc 150 bkl 77.52 Elsevier Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer |
| topic_unstemmed |
ddc 620 ddc 150 bkl 77.52 Elsevier Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer |
| topic_browse |
ddc 620 ddc 150 bkl 77.52 Elsevier Chemotherapy Elsevier Treatment Elsevier Toxicity Elsevier Surgery Elsevier Radiotherapy Elsevier Survival Elsevier Cervical cancer |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a f af v t vt g s gs f f d ff ffd |
| hierarchy_parent_title |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| hierarchy_parent_id |
ELV01225004X |
| dewey-tens |
620 - Engineering 150 - Psychology 300 - Social sciences, sociology & anthropology |
| hierarchy_top_title |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV01225004X |
| title |
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis |
| ctrlnum |
(DE-627)ELV049103679 (ELSEVIER)S0305-7372(19)30166-5 |
| title_full |
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis |
| author_sort |
Marchetti, C. |
| journal |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| journalStr |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 100 - Philosophy & psychology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Marchetti, C. |
| container_volume |
83 |
| class |
620 VZ 150 300 VZ 77.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Marchetti, C. |
| doi_str_mv |
10.1016/j.ctrv.2019.101945 |
| dewey-full |
620 150 300 |
| title_sort |
survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: a systematic review and meta-analysis |
| title_auth |
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis |
| abstract |
• The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. |
| abstractGer |
• The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. |
| abstract_unstemmed |
• The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis |
| url |
https://doi.org/10.1016/j.ctrv.2019.101945 |
| remote_bool |
true |
| author2 |
Fagotti, A. Tombolini, V. Scambia, G. De Felice, F. |
| author2Str |
Fagotti, A. Tombolini, V. Scambia, G. De Felice, F. |
| ppnlink |
ELV01225004X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.ctrv.2019.101945 |
| up_date |
2024-07-06T20:38:55.190Z |
| _version_ |
1803863547122286592 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049103679</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624151916.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200128s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ctrv.2019.101945</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000879.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049103679</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0305-7372(19)30166-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">300</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Marchetti, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The optimal treatment in stage IB2, IIA and IIB cervical cancer is still debated. • Definitive chemoradiothherapy (CRT) is considered the standard treatment. • Neoadjuvant chemotherapy followed by surgery (NACT + S) is a valid option. • This is the first meta-analysis that compares NACT + S versus CRT.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Toxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Surgery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cervical cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fagotti, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tombolini, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scambia, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Felice, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Braun, M.R. ELSEVIER</subfield><subfield code="t">Using regression analysis to predict the future energy consumption of a supermarket in the UK</subfield><subfield code="d">2014</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01225004X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:83</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ctrv.2019.101945</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.52</subfield><subfield code="j">Differentielle Psychologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">83</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.3981476 |